BIT 2.70% 3.8¢ biotron limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-122

  1. 4,185 Posts.
    lightbulb Created with Sketch. 649
    To right…….Biotron’s previous human trials have all been Headline Results, 2014 HCV potentially a Cure, Unfortunate Gilead beat them to the punch with Savoldi. The company chose to go back to the Lab and proceed with the HIV and have made significant advancements over the last 10 years……..Look at the HCV market now lol Great things come to those who wait.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
0.001(2.70%)
Mkt cap ! $34.28M
Open High Low Value Volume
4.0¢ 4.0¢ 3.8¢ $21.54K 566.4K

Buyers (Bids)

No. Vol. Price($)
2 605000 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 502271 6
View Market Depth
Last trade - 13.36pm 08/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.